SCHEMBL20207616

SCHEMBL20207616

C=C(C)c1ccc(N2CCN(C)CC2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 4/20 0.46
HDAC2 Q92769 3/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C18 P33260 1/20 0.45
CYP2C19 P33261 1/20 0.45
KCNH2 Q12809 1/20 0.45
MAPT P10636 2/20 0.44
HTR3A P46098 1/20 0.44
GAA P10253 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
GLA P06280 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ADRA2C P18825 1/20 0.43
GFER P55789 1/20 0.43
PTK2B Q14289 1/20 0.43
ESR2 Q92731 1/20 0.43
CCNK O75909 2/20 0.40
CCND3 P30281 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22159239 0.84 HDAC3 (0.51) HDAC3HDAC2CYP1A2CYP2C18CYP2C19
Ethylene SCHEMBL29031111 0.81 HDAC3 (0.52) HDAC3HDAC2CYP1A2CYP2C18CYP2C19
SCHEMBL63616 0.81 HDAC3 (0.54) HDAC3HDAC2CYP1A2CYP2C18CYP2C19
SCHEMBL25720927 0.80 KDM4E (0.38) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL28314039 0.79 HDAC3 (0.53) HDAC3HDAC2CYP1A2CYP2C18CYP2C19
Lithium Ion SCHEMBL20163088 0.78 HDAC3 (0.49) HDAC3HDAC2CYP1A2CYP2C18CYP2C19
SCHEMBL64453 0.77 HRH3 (0.54) HDAC3HDAC2CYP1A2CYP2C18CYP2C19
SCHEMBL20132431 0.77 HDAC3 (0.57) HDAC3HDAC2CYP1A2CYP2C18CYP2C19
SCHEMBL25693065 0.77 HDAC3 (0.57) HDAC3HDAC2CYP1A2CYP2C18CYP2C19
SCHEMBL733405 0.77 HDAC3 (0.43) HDAC3HDAC2CYP1A2CYP2C18CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098296-A1 PIPERAZINE DERIVATIVES AS SELECTIVE HDAC1,2 INHIBITORS REGENACY PHARMACEUTICALS, LLC (US) 2018-05-31 WO disclosed